Background: Apert syndrome is characterized by craniosynostosis and bony syndactyly of the hands and feet. The cause of Apert syndrome is a single nucleotide substitution mutation (S252W or P253R) in fibroblast growth factor receptor 2 (FGFR2). Clinical experience suggests increased production of saliva by Apert syndrome patients, but this has not been formally investigated. FGFR2 signaling is known to regulate branching morphogenesis of the submandibular glands (SMGs). With the Apert syndrome mouse model (Ap mouse), we investigated the role of FGFR2 in SMGs and analyzed the SMG pathology of Apert syndrome. Results: Ap mice demonstrated significantly greater SMG and sublingual gland (SMG/SLG complex) mass/body weight and percentage of parenchyma per unit area of the SMG compared with control mice. Furthermore, gene expression of Fgf1, Fgf2, Fgf3, Pdgfra, Pdgfrb, Mmp2, Bmp4, Lama5, Etv5, and Dusp6 was significantly higher in the SMG/SLG complex of Ap mice. FGF3 and BMP4 exhibited altered detection patterns. The numbers of macrophages were significantly greater in SMGs of Ap mice than in controls. Regarding functional evaluations of the salivary glands, no significant differences were observed. Conclusions: These results suggest that the gain-of-function mutation in FGFR2 in the SMGs of Ap mice enhances branching morphogenesis.
Introduction
Apert syndrome (OMIM: 101200) is a congenital disorder characterized by craniosynostosis, midface hypoplasia, and bony syndactyly of the hands and feet. It also involves mental deficiency, fusion of cervical vertebrae, hyperhidrosis, interrupted eyebrows, and ophthalmic symptoms such as amblyopia, strabismus, anisometropia, and ametropia. Apert syndrome is caused by one of two missense mutations of the fibroblast growth factor receptor (FGFR) 2 gene, involving the following amino acid substitutions: S252W or P253R. These result in ligand-dependent gain-of-function of FGFR2 (Anderson et al., 1998; Wilkie et al., 1995) .
The fibroblast growth factor (FGF) family includes 22 members that have been identified based on sequence homology. Eighteen of these FGFs interact with four membrane-spanning tyrosine kinases, known as FGFRs, in humans and mice (Brewer et al., 2016) . FGF/FGFR signaling functions during the earliest stages of embryonic development and organogenesis to maintain progenitor cells and to mediate their growth, differentiation, survival, and patterning. This signaling also is active in adult tissues, where these complexes mediate metabolic functions, tissue repair, and regeneration (Ornitz and Itoh, 2015) . FGFRs contain a hydrophobic leader sequence, three immunoglobulin-like domains (IgI-III), a linker region, an acidic box, a transmembrane region, and a divided tyrosine kinase domain. The IgIII domains of FGFR1-3 are encoded by exons 7-9. Inclusion of either exon 8 or 9 produces the IIIb ("b") or IIIc ("c") splice isoform. This alternative splicing event is regulated in a tissuespecific fashion, with IIIb expression restricted to epithelial lineages and IIIc to mesenchymal lineages (Beer et al., 2000; Orr-Urtreger et al., 1993; Wuechner et al., 2004) . These splicing variants exhibit ligand specificity: FGFR2b mainly binds to FGF3, 7, 10, and 22, whereas FGFR2c has a high affinity for FGF4, 5, 6, 8, 9, 16, 17, 18, 19, and 20 (Ornitz and Itoh, 2015) . Apert syndrome mutations cause loss of ligand specificity of FGFR2 isoforms and enhancement of binding affinity (Yu et al., 2000) . IgII, IgIII, and the linker region contribute to the binding of FGF (Plotnikov et al., 1999) . Apert syndrome mutations may alter the conformation of the linker region and change the relative orientations of IgII and IgIII, which is considered the cause of Apert syndrome mutations that modify ligand specificity (Yu et al., 2000) .
In the past 15 years, two independent transgenic mouse models, Fgfr2 +/S252W (Chen et al., 2003; Wang et al., 2005) and Fgfr2 +/P253R Yin et al., 2008) , have been established. Similar to Apert syndrome patients, both models show phenotypes such as early coronal suture fusion and midfacial hypoplasia. These mouse models are used to comprehend the pathology in calvaria (Du et al., 2010; Holmes et al., 2009 ), brain (Aldridge et al., 2010; Hill et al., 2013) , and long bone , and to evaluate novel targets and strategies for the treatment of Apert syndrome Shukla et al., 2007; Yokota et al., 2014) . Although clinical observation suggests that there is increased salivary production in Apert syndrome patients, salivary glands have not been formally investigated in either the mouse model or human patients.
Salivary glands have important roles, such as providing lubrication for eating and vocalization, supporting digestion and tasting, providing antimicrobial activity, and serving as a pH buffer. In mammals, there are three main paired salivary glands: submandibular, sublingual, and parotid glands. During development, salivary glands exhibit branching morphogenesis, which is a developmental behavior common in several organs such as the lungs, lacrimal glands, mammary glands, and pancreas. The submandibular gland (SMG) has been used as a model for studying branching morphogenesis (Patel et al., 2006) . In mice, SMG development begins at embryonic day 11.5 (E11.5) as an epithelial thickening, which becomes an initial bud by E12.5. This initial bud then undergoes clefting and elongation, forming a network of epithelial stalks capped by end buds, surrounded by neural crest-derived mesenchyme. In addition to branching morphogenesis, lumen formation begins at E15.5. A tubular system that enables the passage of saliva is completed by E17.5.
From observations in knockout mice and ex vivo experiments, FGF/FGFR signaling is considered to play key roles in the development of SMGs. Fgfr2b -/mice and Fgf10 -/mice display aplasia of SMGs, such that a single epithelial bud is appropriately formed, but it degenerates before the initiation of branching morphogenesis (Jaskoll et al., 2005; Moerlooze et al., 2000; Ohuchi et al., 2000) . FGFR1b is expressed in SMG epithelium at approximately E14.5 (Hoffman et al., 2002) , and FGFR1b and FGFR2b signals up-regulate the expression of each other (Rebustini et al., 2007) . FGFR signals control several factors, such as FGF1, FGF2, FGF3, FGF7, FGF10, bone morphogenetic protein (BMP) 4, BMP7, laminin α5 (Lama5), matrix metalloproteinase (MMP) 2, Ets (E26 transformation-specific) variant (ETV) 4, ETV5, and dualspecificity phosphatase (DUSP) 6 (Camps et al., 1998; Hoffman et al., 2002; Rebustini et al., 2007; Steinberg et al., 2005; Tsang and Dawid, 2004) . Morita et al. cultured mesenchyme-free SMG epithelial explants in medium containing FGF7, revealing that FGF7 promotes stalk elongation of the SMG epithelium (Morita and Nogawa, 1999) . FGF1 is necessary for branching, as a combination of neutralizing antibodies to FGF1, FGF7, and FGF10 is required to inhibit the branching of E13.5 glands in culture (Steinberg et al., 2005) . Hoffman et al. suggested that FGF3, FGF7, FGF10, and BMP7 exhibit positive regulatory effects on the number and size of epithelial buds. In contrast, FGF2 and BMP4 play negative regulatory roles and potentially decrease epithelial cell proliferation; they may define the sites of cleft formation (Hoffman et al., 2002) . Lama5 contributes to cleft formation because SMGs of Lama5 -/mice show delayed epithelial clefting (Rebustini et al., 2007) . MMP2 expression, which influences SMG morphogenesis, is downstream of FGFR2b. Increased MMP2 activity may increase extracellular matrix (ECM) remodeling and FGFR cleavage, allowing localized expansion of the epithelium into the ECM at sites where proliferation occurs (Steinberg et al., 2005) . Upon binding to FGFRs, FGFs activate multiple intracellular cascades, including PI3K-and MEK1/2-dependent signaling (Tsang and Dawid, 2004) . MEK1/2 activates members of the Ets transcription factor family, such as ETV4 and ETV5, and negative regulators of the FGF signaling pathways, such as DUSP6 (Camps et al., 1998; Tsang and Dawid, 2004) .
In regard to salivary production, the secretion of fluid and electrolytes by acinar cells requires coordinated regulation of multiple water and ion transporter and channel proteins, such as aquaporin 5, K + and Cl − channels, the Na + /K + /2Cl − cotransporter, and Na + /H + and Cl − =HCO − 3 exchangers. All key transporter and channel proteins in this process are activated by an increase in the muscarinic-induced intracellular Ca 2+ concentration ([Ca 2+ ] i ) (Ambudkar, 2016; Melvin et al., 2005) .
From the above, we suspect that Ap mice exhibit hyperplastic SMGs due to gain-of-function in FGFR2, which causes increased salivary production. Although it has not been reported that Apert syndrome patients suffer from hypersalivation in daily life, it is important to elucidate how Fgfr2 is involved in saliva production for better understanding of salivary gland functions. This is expected to elucidate the pathology of Apert syndrome and to evaluate novel targets and strategies for the treatment of xerostomia. The purpose of the present study was to investigate morphological and functional phenotypes of SMGs in Fgfr2 +/S252W mice (Ap mice).
Results

Overgrowth of Submandibular and Sublingual Salivary Glands in Ap Mice
As an initial stage of this research, we generated Ap mice by crossing Fgfr2 +/Neo-S252W mice and homozygous ACTB-Cre mice. General inspection of whole-body appearance at postnatal day 1 (P1) indicated that Ap mice showed dome-shaped heads and were apparently smaller than heterozygous ACTB-Cre mice (control mice, littermates of Ap mice) ( Fig. 1A) . The body weight of Ap mice was significantly lower than that of ACTB-Cre mice (Fig. 1C ), supporting our visual observations. Phenotypes observed in this study were similar to those reported in a previous study, in which EIIa-Cre mice were used in place of homozygous ACTB-Cre mice .
To investigate macroscopic phenotypes of SMGs and sublingual glands (SLGs) in Ap mice, SMGs and SLGs at P1 were collected en bloc, as SMG/SLG complexes, separately on the right and left sides. General inspection of the gross appearance of the SMG/SLG complexes at P1 indicated that the SMG/SLG complexes of Ap mice tended to be slightly larger than the SMG/SLG complexes of ACTB-Cre mice (Fig. 1B) . Measurement of SMG/SLG complex mass on both sides indicated that the SMG/SLG complex mass of Ap mice tended to be slightly heavier than that of control mice, although there was no significant difference (Fig. 1D ). Furthermore, proportions of SMG/SLG complex masses in body weight of Ap mice were significantly greater than those of control mice (Fig. 1E ).
Hyperplasia in the Parenchyma of SMGs in Ap Mice
Next, we observed SMGs histologically by hematoxylin and eosin (H&E) staining. Figure 2A shows narrower interlobular connective tissue in Ap mice compared with control mice (bidirectional arrows in Fig. 2A ). To quantify this observation, we performed image analysis of histological sections. The proportion of parenchymal area to a unit area (parenchymal occupancy rate) was significantly greater (Fig. 2B ), and the total area of parenchyma was significantly reduced (Fig. 2C ) in SMGs of Ap mice compared with those of control mice. Conversely, there were no significant differences in SLGs between Ap mice and control mice. These data indicate that the parenchyma of SMGs is hyperplastic in Ap mice.
Altered Gene Expression in the SMG/SLG Complex of Ap Mice
To elucidate the genetic mechanisms involved in the morphological phenotypes in SMG, expression of genes related to the development of SMG, such as Fgf1, Fgf2, Fgf3, Fgf7, Fgf10, Fgfr1, Fgfr2, Pdgfa, Pdgfb, Pdgfra, Pdgfrb, Mmp2, Bmp4, Bmp7, Lama5, Etv4, Etv5, and Dusp6, were evaluated. The results of real-time reverse transcription polymerase chain reaction (RT-PCR) analysis of the SMG/SLG complex showed that the mRNA transcriptional levels of Fgf1, Fgf2, Fgf3, Pdgfra, Pdgfrb, Mmp2, Bmp4, Lama5, Etv5, and Dusp6, were significantly higher in Ap mice compared with control mice (Fig. 3A,B ).
Altered BMP4 and FGF3 Detection Pattern in SMGs of Ap Mice
To explore the detection pattern of proteins encoded by Fgf1, Fgf3, Fgf7, Fgf10, Fgfr2, Pdgfra, Pdgfrb, BMP4, and Etv5, immunohistochemistry (IHC) was performed. As common findings in Ap mice and control mice, FGF1, FGF3, FGF7, FGF10, FGFR2, BMP4, and ETV5 were detected in parenchyma, while PDGFRA and PDGFRB were detected in the interstitium of SMGs (Fig. 4A ). Furthermore, FGF1, FGF3, FGF7, and FGF10, which are ligands for FGFR2b, were detected in parenchymal cells and on parenchymal cell membranes in SMGs, in a manner similar to FGFR2 (Fig. 4A ). IHC analysis of FGFR2 and FGF3 was performed with adjacent paraffin sections, showing co-expression of FGFR2 and FGF3 in similar epithelial cells ( Fig. 4A ). Also, IHC analysis of ETV5 and FGF3 using adjacent paraffin sections demonstrated that ETV5 and FGF3 were detected in similar epithelial cells (Fig. 4B) . In a comparison of Ap mice and control mice, FGF3 and BMP4 tended to be expressed more in SMGs of Ap mice (Fig. 4A ). To confirm this finding, we analyzed the proportion of protein-positive area (detection rate) to overall parenchyma and interstitium. We found that proportions of FGF3 and BMP4 to parenchyma, and of BMP4 to interstitium, were significantly higher in Ap mice compared with control mice (Fig. 4C,D) .
Increased Numbers of Macrophages in SMGs of Ap Mice
During IHC analysis of BMP4, positive circular cells were observed in the interstitium of SMGs (Fig. 4A ). We hypothesized that they were macrophages because expression of macrophages was confirmed in the mesenchyme of the SMG during the embryonic phase (Sathi et al., 2017) . To verify this hypothesis, IHC analysis of BMP4 and F4/80 (a marker for macrophages) was performed with adjacent paraffin sections. Notably, F4/80-positive cells were similar in shape and were observed in similar locations as BMP4-positive cells ( Fig. 5A ) (image of ACTB-Cre mouse not shown). Therefore, the BMP4-positive circular cells were categorized as BMP4-positive macrophages. Ap mice tended to exhibit higher macrophage and BMP4-positive macrophage numbers than control mice ( Fig. 5B ). Following statistical analysis, a significant difference was confirmed ( Fig. 5C ).
No Significant Differences in Functional Analyses
To investigate functional phenotypes in SMGs of Ap mice, realtime RT-PCR was performed to evaluate expression of Aqp5, Chrm3, Ano1, and Slc12a2, which encode aquaporin 5, muscarinic acetylcholine receptor M3, Cl − channel, and Na + /K + /2Cl − cotransporter, respectively. There were no significant differences in gene expression of Aqp5, M3, Ano1, and Slc12a2 among the groups (Fig. 6A ). In addition, carbachol (Cch)-induced [Ca 2+ ] i of the acinar cells in SMGs was measured. There was no significant difference among the groups (Fig. 6B,C ).
Discussion
FGF/FGFR signals play important roles during development of the SMG. Although several studies have demonstrated these roles via FGF or FGFR knockout mouse models and ex vivo examinations with FGFR ligands or inhibitor treatment, the effect of FGFR2 enhancement on SMG function in vivo has not previously been addressed. Here, we have shown, for the first time, in vivo phenotypes of SMGs in Ap mice, based on a gain-offunction of FGFR2.
Jayasinghe et al. indicated that the salivary glands of males and females are similar in many respects at P1; however, the volume proportions of the acini in glands of females were higher than those in glands of males (Jayasinghe et al., 1990) . To verify whether this report affects the data obtained by our experimental method, we checked whether there were sex differences within each group of Ap mice and ACTB-Cre mice. Our results showed that, among all experimental results in this study, there were no sex differences within each group of Ap mice and ACTB-Cre mice (data not shown).
In this study, we revealed overgrowth of the SMG/SLG complex and hyperplastic parenchyma in SMG in Ap mice. Jaskoll et al. indicated that FGF10/FGFR2b signaling plays an essential, dose-dependent role during in vivo embryonic SMG branching morphogenesis and histodifferentiation after their observations of Fgfr2b-and Fgf10-null and heterozygous mutant mice (Jaskoll et al., 2005) . Steinberg et al. cultured isolated epithelial rudiments of SMG in serum-free medium, with or without FGFs. Although the epithelial rudiments did not grow without exogenous growth factors and ECM, FGF7 promoted budding of the epithelial rudiment with short ducts, whereas FGF10 promoted duct elongation without enlargement of epithelial buds and increased both the length and number of branches. Furthermore, chemical inhibitors, such as SU5402 (an inhibitor of FGFR phosphorylation), UO126 (a MEK1/2 inhibitor), LY294002 (a PI3K inhibitor), GO6983 (a broad PKC inhibitor), and soluble recombinant FGFR isoform, were added to epithelial rudiments. The results suggested that FGFR1b plays a role in FGF7-mediated morphogenesis, possibly downstream of FGF7/FGFR2b signaling, and that epithelial budding requires both PI3K-and MEK1/2-dependent signaling, whereas duct elongation requires MEK1/2-dependent signaling (Steinberg et al., 2005) . Furthermore, MEK1/2 activates Etv4, Etv5, and Dusp6, known as FGFR-responsive genes (Camps et al., 1998; Tsang and Dawid, 2004) . mRNA expression of Etv5 and Dusp6 was up-regulated in Ap mice compared with control mice (Fig. 3B) . Taken together, our data suggest progression of branching morphogenesis by up-regulation of MEK1/2-dependent signaling due to gain-of-function of FGFR2 in Ap mice. Platelet-derived growth factor (PDGF) signals also play important roles in SMG branching morphogenesis. A recent report indicates that FGFs function downstream of PDGF signaling, which regulates Fgf expression in neural crest-derived mesenchymal cells and SMG branching morphogenesis (Yamamoto et al., 2008) . In this study, mRNA expression of Pdgfra and Pdgfrb was increased in the Ap SMG/SLG complex (Fig. 3B) , which suggests that FGFR2 signals are regulated by, and also regulate, PDGF signals.
mRNA expression of Fgf1, Fgf2, and Fgf3 was up-regulated in Ap mice compared with control mice (Fig. 3A) . These upregulations were obviously results of activated FGFR2. Ornitz et al. demonstrated that FGF1 can activate all FGFR splice variants; FGF2 activates FGFR1, FGFR2c, FGFR3c, and FGFR4; and FGF3 activates FGFR1b and FGFR2b (Ornitz and Itoh, 2015) . Yu et al. suggested that the Apert syndrome mutation may alter the conformation of the linker region and change the relative orientation of IgII and IgIII because Apert syndrome mutations alter ligand specificity (Yu et al., 2000) . In the SMG/SLG complex, the Apert syndrome mutation alters the ligand specificity of FGFR2, and these FGFs may exhibit increased binding affinity with FGFR2. Thus, it is expected that these FGFs may cause further activation of FGFR2, which gains function in a liganddependent manner due to the Apert syndrome mutation in Ap mice. In particular, FGF3 was more frequently detected in the parenchyma of Ap SMGs compared with control SMGs (Fig. 4A,  B) ; its receptor, FGFR2b, is thought to be expressed in parenchyma derived from epithelium. Additionally, mRNA expression of Etv5 and Dusp6 (FGFR-responsive genes) was significantly greater in Ap mice than in ACTB-Cre mice (Fig. 3B ). Furthermore, FGFR2 and FGF3 (Fig. 4A ) as well as ETV5 and FGF3 (Fig. 4B) were detected in similar epithelial cells with adjacent paraffin sections, especially in Ap mice. These results suggest that FGF3-FGFR2-ETV5 signaling cascade is activated within the same cell. Taken together, it is presumed that FGF3 binds to FGFR2b in an autocrine or paracrine fashion, and that positive spiral activation of FGF3/FGFR2b signal occurs. mRNA expression of Mmp2 was also up-regulated in Ap mice. As Hoffman et al. discussed (Hoffman et al., 2002) , MMP2 may increase ECM remodeling and assist parenchymal expansion into the ECM at the site where proliferation occurs due to the activated FGFR signal in Ap SMGs.
BMP4 is a known inhibitory factor for salivary gland branching morphogenesis (Hoffman et al., 2002) . In this study, the expression of Bmp4 was up-regulated ( Fig. 3B ) and detected more frequently in the parenchyma and interstitium (Fig. 4) of Ap mice. BMP4 up-regulation in response to increased FGFR2 signaling is explained by the possibility that BMP4 is under negative feedback control of enhanced branching morphogenesis. BMP4 is also known as a macrophage chemotactic factor (Yamamoto et al., 2008) . Thus, many macrophages were observed in Ap SMGs (Fig. 5) . Macrophages have been detected during branching morphogenesis of several glands, and they have been shown to direct tissue growth (Cecchini et al., 1994; Jones et al., 2013) . In the absence of macrophages, terminal buds in the mammary gland are atrophic and poorly branched (Gouon-Evans et al., 2000) . Sathi et al. detected macrophages in the mesenchyme close to epithelial buds at E15.5 in normal SMGs (Sathi et al., 2017) . Taken together, increased macrophages in Ap mice may contribute to overgrowth of the SMG.
Lama5 is regulated by FGFR1b and FGFR2b and encourages cleft formation in SMGs (Rebustini et al., 2007) . Although evaluation of branching was not performed in this study, increased Lama5 expression was observed in Ap mice (Fig. 3B) . Thus, it is expected that not only proliferation, but also branching, is enhanced in Ap SMG.
Ap mice died early postnatally, so functional analyses, such as saliva secretion tests and measurement of saliva components, could not be performed. Therefore, we investigated gene expression with respect to function and performed Ca 2+ -imaging. In terms of functional evaluations, no significant differences were observed in mRNA expression of Aqp5, Chrm3, Ano1, and Slc12a2, or in Cchinduced [Ca 2+ ] i of acini between Ap and control mice (Fig. 6) . Our results showed that the SMG could exhibit morphological changes, whereas the SLG could not (Fig. 2) . The SMG in mice comprises primarily pure serous acinar cells, whereas the SLG comprises both serous and mucous acinar cells (Amano et al., 2012) . This suggests that moisture in the saliva of Ap mice and components from the serous acinar cells, such as amylase, may increase; however, components such as mucin do not change compared with ACTB-Cre mice. May et al. indicated that Fgf10-heterozygous mutant mice showed a significant reduction in saliva flow from the SMG compared with their wild-type littermates. Their results suggested that the hyposalivation observed in Fgf10-heterozygous mutant mice is due to reduction in the size of the gland (May et al., 2015) . Taken together, although there are no differences at a cellular level, these data suggest that the amount of saliva is increased at an individual level because the SMG parenchyma is hyperplastic in Ap mice. Further studies are needed to characterize saliva production in Ap mice.
In conclusion, this study has demonstrated SMG phenotypes in Ap mice. We have revealed hyperplasia in the parenchyma of SMGs due to a gain-of-function mutation in FGFR2; this activated FGFR2 enhances SMG branching morphogenesis by regulation of Fgf1, Fgf2, Fgf3, Pdgfra, Pdgfrb, Mmp2, Bmp4, Lama5, Etv5, and Dusp6 in vivo. It is likely that BMP4 suppresses branching morphogenesis and simultaneously causes macrophage migration, which encourages SMG branching morphogenesis.
Experimental Procedures
Generation of the Apert Syndrome Mice Model
Fgfr2 +/Neo-S252W mice and ACTB-Cre mice (Lewandoski et al., 1997) have been described previously. Fgfr2 +/Neo-S252W mice were generously gifted by Dr. Chu-Xia Deng; homozygous ACTB-Cre mice, in which the cre gene was placed under the control of regulatory elements from the human β-actin gene such that it functions in all cells of the embryo at or before the blastocyst stage, were purchased from The Jackson Laboratory (600 Main Street Bar Harbor, ME USA 04609). Crossing between male homozygous ACTB-Cre mice and female Fgfr2 +/Neo-S252W mice generated heterozygous ACTB-Cre and Ap mice. These mice were genotyped by PCR analysis of genomic DNA prepared from tail tips with primers specific for Fgfr2, Fgfr2 Neo-S252W , Fgfr2 S252W , and Cre. The primers for Fgfr2, Fgfr2 Neo-S252W , and Fgfr2 S252W have been described previously (Shukla et al., 2007) . Primer sequences for Cre were F-5 0 -GCGGTCTGGCAGTAAAAACTATC-3 0 and R-5´-GTGAAACAG-CATTGCTGTCACTT-3 0 , as published on the Jackson Laboratory website. All experiments were performed in accordance with the experimental design certified by the Animal Research Committee of Kyushu Dental University (experiment No. 17-021).
Measurement of Gland Mass and Histological Analysis
The body weight of newborn mice was measured. SMG/SLG complexes were collected, and the masses of bilateral SMG/SLG complexes were measured. SMG/SLG complexes, mass to body weight, were calculated. The sample size of each group was 13 (male: seven; female: six). SMG/SLG complexes were fixed in 10% formalin and 4% paraformaldehyde over 24 hr for H&E staining and IHC, respectively, then embedded in paraffin, sliced to a thickness of 4 μm, and observed under a microscope (BX50F4; Olympus, Tokyo, Japan). For immunostaining, sections were incubated in methanol containing 0.3% hydrogen peroxide for 30 min before washing with phosphate buffered saline (PBS) and incubation with PBS containing 5% skim milk for 1 h. For FGFR2 immunostaining, antigen retrieval was performed as follows: The deparaffinized slides were incubated in citric acid buffer (pH 6.0) and treated with microwave heating for 5 min. Then the slides were washed with 0.05 M Tris-Cl buffer (pH 7.6) prior to methanol incubation. Primary antibodies were allowed to stand for 8 hr or more at 4 C and were detected with secondary antibodies. Primary antibodies used were rabbit polyclonal to FGF1 (36770; Signalway Antibody, MD, USA, 1:50), FGF3 (bs-1255R; Bioss Antibodies, MA, USA, 1:200), FGF7 (31162; Signalway Antibody, 1:200), FGF10 (AP7975B; Abgent, CA, USA, 1:200), FGFR2 (33372; Signalway Antibody, 1:50), PDGFRB (BS1763; Bioworld Technology, MN, USA, 1:200), BMP4 (bs-1374R; Bioss Antibodies, 1:200), ETV5 (GTX114394; Gene Tex, CA, USA, 1:100); goat polyclonal to PDGFRA (AF1062; R&D Systems, MN, USA, 1:200); and rat monoclonal to F4/80 (MCA497; Bio-Rad, CA, USA, 1:200). Secondary antibodies used were goat anti-rabbit antibody (BA-1000; Vector Laboratories, CA, USA), rabbit anti-goat antibody (BA-5001; Vector Laboratories), and rabbit anti-rat antibody (BA-4001; Vector Laboratories). H&E staining and IHC were performed of the unilateral SMG/SLG complex, separately on the right and left. Sample sizes of each group were eight glands from eight mice (male: four; female: four) for H&E staining, and six glands from six mice (male: three; female: three) for IHC.
Image Analysis
Discrimination of parenchyma, interstitium, and proteindetected region Images observed by H&E staining and IHC were digitized in the JPEG format of 24-bit RGB color model with an image resolution of 72 ppi by using a microscopic digital camera (DP74; Olympus) and microscopic imaging software (cellSens Standard; Olympus). The following analyses were performed with ImageJ (ImageJ). Acquired images were converted to 8-bit gray-scale. Binary images were prepared with luminance thresholds of 180 for H&E staining; foreground and background were defined as parenchyma and interstitium, respectively. In IHC, there were two patterns: parenchyma stained densely and interstitium stained densely. In the former, parenchyma was defined as the region where luminance was below 195 and the area was not < 810 μm 2 . In the latter, parenchyma was defined as the area inside of luminance border in 180 and the area was not < 2000 μm 2 , excluding the region where luminance was below 140. The protein-detected region was defined with luminance thresholds of 180 and 160 for the two patterns, respectively.
Calculation of parenchyma occupancy rate
As regions of interest (ROIs), 10 squares, 200 μm per side, were applied at random in each SMG. Parenchyma occupancy rates were calculated with the following formula:
ðparenchyma area within ROIsÞ=ðROIs areaÞ: Fgf1; (Yamamoto et al., 2008) Forward primer GCACCGTGGATGGGACAAGGGACAGGAG Reverse primer CACTTCGCCCGCACTTTCCGCACTGAG Fgf2; (Yamamoto et al., 2008) Forward primer GCGAGAAGAGCGACCCACAC Reverse primer GAAGCCAGCAGCCGTCCATC Fgf3; (Yamamoto et al., 2008) Forward primer ACCCGCCGCACACAAAAGTCCTCTCTCTTC Reverse primer TCTGCTTCTTCTGCCTCCGCTGCCTGG Fgf7; (Yamamoto et al., 2008) Forward primer CAGCCCCGAGCGACACACCAGAAGTTATG Reverse primer TCCTGGGTCCCTTTCACTTTGCCTCGTTTG Fgf10; (Yamamoto et al., 2008) Forward primer CCTCCTCGTCCTTCTCCTCTCCTTCCAGTG Reverse primer CCGCTGACCTTGCCGTTCTTCTCAATCGTG Fgfr1; (Huang et al., 2014) Forward primer TTCAGTGGCTGAAGCACATC Reverse primer GCAGAGTGATGGGAGAGTCC Fgfr2; (Huang et al., 2014) Forward primer GTGCTTGGCGGGTAATTCTA Reverse primer GATGACTGTCACCACCATGC Pdgfa; (Yamamoto et al., 2008) Forward primer CAAGACCAGGACGGTCATTT Reverse primer CCTCACCTGGACCTCTTTCA Pdgfb; (Yamamoto et al., 2008) Forward primer CCCTGCTCCACAAAGGCGGG Reverse primer CCTAGCCCGGTGCCTCGTCT Pdgfra; (Yamamoto et al., 2008) Forward primer ACAGAGACTGAGCGCTGACA Reverse primer CACCAGGTCCGAGGAATCTA Pdgfrb; (Yamamoto et al., 2008) Forward primer ACGTACCCTACGACCACCAG Reverse primer TCCATTGGAAGTTCACCACA Mmp2; Forward primer CAGGGAATGAGTACTGGGTCTATT Reverse primer ACTCCAGTTAAAGGCAGCATCTAC Bmp4; Forward primer GAGGAGTTTCCATCACGAAGA Reverse primer GCTCTGCCGAGGAGATCA Bmp7; (Liu et al., 2015) Forward primer CAGCCACCAGCAACCACT Reverse primer GTCCATGCCGTCCAATCA Lama5; (Chiang et al., 2013) Forward primer ACCCAAGGACCCACCTGTAG Reverse primer TCATGTGTGCGTAGCCTCTC Etv4; (Koo et al., 2005) Forward primer ATCATGCAGAAGGTGGCTGG Reverse primer CCGGTCAAACTCAGCCTTCA Etv5; (Koo et al., 2005) Forward primer AAGAGGTTGCTCGCCGTTG Reverse primer CCTTCTGCATGATGCCCTTTT Dusp6; (Morrison et al., 2008) Forward primer TCGGGCTGCTGCTCAAGAAAC Reverse primer CGGTCAAGGTCAGACTCAATGTCC Aqp5; (Zheng et al., 2012) Forward primer GGCCCTCTTAATAGGCAACC Reverse primer TTGCCTGGTGTTGTGTTGTT Chrm3; (Gericke et al., 2011) Forward primer CCTCTTGAAGTGCTGCGTTCTGACC Reverse primer TGCCAGGAAGCCAGTCAAGAATGC Ano1; (Song et al., 2014) Forward primer CAAGGGTTTCTTTGGCTAT-3 Reverse primer TCACCTGAGATATTTGCTCC Slc12a2; (Lian et al., 2017) Forward primer GAAGCGGAAGCAGCGCTATG Reverse primer AGTGGAGCCAGAGGGAAGGA Gapdh; (Yamamoto et al., 2008) Forward primer GGAGCGAGACCCCTCTAACATC Reverse primer CTCCTGGTTCACACCCATCAC
Measurement of total area of parenchyma
As a ROI, the SMG was selected with the polygon-selection tool. The total area of the parenchyma, equal to or larger than 810 μm 2 , was measured with the analyze-particles tool.
Calculation of protein detection rate
As ROIs, 10 squares, 200 μm per side, were applied at random in each SMG. The area of interstitium, as well as parenchyma and interstitium protein-detection rates, were calculated with the following formulas: 
Quantitative and Real-time RT PCR
Total RNA was isolated from one side of SMG/SLG complex using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. Total RNA (2 μg) was reverse-transcribed into cDNA in 20 μl of 1× first-strand buffer containing 0.5 μg of oligo (dT) as a primer, 500 μM dNTP, and 200 units of Super-Script III (Invitrogen). Real-time PCR was performed on the obtained cDNA using THUNDERBIRD SYBR qPCR Mix (QPS-201; Toyobo, Osaka, Japan) and a real-time PCR detector (7300 Real-time PCR System; Thermo Fisher Scientific). Primers for Fgf1, Fgf2, Fgf3, Fgf7, Fgf10, Fgfr1, Fgfr2, Pdgfa, Pdgfb, Pdgfra, Pdgfrb, Mmp2, Bmp4, Bmp7, Lama5, Etv4, Etv5, Dusp6, Aqp5, Chrm3, Ano1, Slc12a2, and Gapdh were prepared as previously described. The primers used are shown in Table 1 (Chiang et al., 2013; Gericke et al., 2011; Huang et al., 2014; Jin et al., 2016; Koo et al., 2005; Lian et al., 2017; Liu et al., 2016; Morrison et al., 2008; Song et al., 2014; Yamamoto et al., 2008; Zheng et al., 2012) . Relative expression level was quantified with the ΔΔCt method (Livak and Schmittgen, 2001) . The sample size of each group was four glands from four mice.
Ca 2+ -imaging
The Ca 2+ -imaging technique was used to investigate whether acinar cells in salivary glands showed different physiological functions in each group. The cell preparation has been previously described (Nakamura-Kiyama et al., 2014) . One side of a SMG/SLG complex was immediately removed and placed in a cold balanced salt solution (BSS) and 0.5% bovine serum albumin. After mincing, the material was digested for 30 min at 37 C with 50 U/mL collagenase (Wako, Osaka, Japan) in BSS. The cell preparations were loaded with 2 μM fura-2AM (Dojindo, Kumamoto, Japan), which was suspended in 10 mL of BSS, and incubated for 30 min at room temperature. After the cell preparation was dispersed on dishes, the dishes were mounted on the stage of an inverted fluorescence microscope (Olympus, Tokyo, Japan) and perfused with BSS at a rate of 1 mL/min at room temperature. The excitation of fura-2 was induced every second by alternate illuminations of 340 and 380 nm light, and the resultant fluorescence (510-550 nm; F340 and F380) was measured using an objective lens (Olympus, Tokyo, Japan) and a silicon-intensified target camera (Hamamatsu Photonics, Hamamatsu, Japan). One micromolar, 3 μM, and 10 μM Cch (Wako) was applied to the cells by flow from separate storage bottles that contained media to which Cch had been added. Acini were observed as spherical or ovoid structures that had a globular appearance, while the ducts showed obvious tubular structures. The ratio of F340 to F380 (F340/F380) was used as a relative indicator for [Ca 2+ ] i . The [Ca 2+ ] i responses induced by Cch were expressed as ΔF340/F380, which is the difference between minimum F340/F380 before Cch application and maximum F340/ F380 during Cch application. The average of ΔF340/F380 of 10 acini was taken as ΔF340/F380 of a sample. The sample size of each group was five glands from five mice.
Statistical Analysis
The Mann-Whitney U test was used to determine differences in body weight, SMG/SLG complex mass, SMG/SLG complex mass/ body weight, parenchyma occupancy rate, total area of parenchyma, protein-detection rate of acini and ducts, expression level of gene group related to FGF signal in salivary gland development, expression level of genes related to salivary gland function, and ΔF340/F380. P value < 0.05 was considered statistically significant.
